tiprankstipranks
Trending News
More News >

Innovent Biologics Completes HK$4.27 Billion Share Placement

Story Highlights
Innovent Biologics Completes HK$4.27 Billion Share Placement

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from Innovent Biologics ( (HK:1801) ).

Innovent Biologics, Inc. has successfully completed the placement of 55,000,000 new shares under its General Mandate, raising approximately HK$4,265.4 million. This strategic move allows the company to continue its growth trajectory by leveraging the General Mandate to issue additional shares, enhancing its financial flexibility and market positioning.

The most recent analyst rating on (HK:1801) stock is a Buy with a HK$65.98 price target. To see the full list of analyst forecasts on Innovent Biologics stock, see the HK:1801 Stock Forecast page.

More about Innovent Biologics

Innovent Biologics, Inc. is a biotechnology company incorporated in the Cayman Islands, focusing on the development, manufacture, and sale of biologic products. The company is listed on the Hong Kong Stock Exchange under the stock code 1801.

Average Trading Volume: 26,330,143

Technical Sentiment Signal: Buy

Current Market Cap: HK$131B

For an in-depth examination of 1801 stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1